Veliparib ER is under clinical development by AbbVie and currently in Phase II for Myeloproliferative Disorders.

Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells in the body. They differ based on which type of blood cell is ...

Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers involving the uncontrolled replication of cells derived from myeloid stem cells.

HMPL-306 is under clinical development by Hutchison MediPharma and currently in Phase I for Myeloproliferative Disorders.

Myeloproliferative diseases are a heterogeneous group of conditions characterized by excessive cellular proliferation of one or more types of peripheral blood cells.

One research noted the persistent efforts to develop new treatments for myeloproliferative neoplasms (MPNs), a commitment ...

Managing a younger person with a myeloproliferative neoplasm (MPN) includes a lot of long-term considerations, including ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

An MPN advocate used his personal experiences to inform his dedication to patient-centered research and support programs for ...